Dean, College of Medical Technology · Professor of Medical Laboratory Science and Biotechnology
A translational scientist and academic leader connecting telomere biology, mitochondrial science, regenerative medicine and biomedical commercialization.
Current appointments
Dean, College of Medical Technology, Chung Hwa University of Medical Technology (since 2021)
Professor, Department of Medical Laboratory Science and Biotechnology / Graduate Institute of Biomedical Science (since 2008)
Joint Professor, Universitas Muhammadiyah Surabaya, Indonesia (since 2026)
Joint Professor, College of Life Sciences, Kaohsiung Medical University (from 2026)
Education & international training
B.S. in Medical Technology and M.S./Ph.D. in Medicine, Kaohsiung Medical University; first-ranked doctoral graduate and recipient of an outstanding dissertation award. Exchange scholar at the University of Queensland under a Taiwan–Australia bilateral program.
Selected leadership & honors
Former Vice President and Dean of Academic Affairs, Chung Hwa University of Medical Technology
Reviewer for national science, education, SBIR and innovation programs
National Teacher of the Year Award, Ministry of Education
International invention awards and long-term national research support
Research focus
Telomere biology & cellular aging
Mitochondrial bioenergetics
Stem-cell & regenerative medicine
Translational natural bioactives
Academic & innovation impact
~60SCI-indexed papers
34invention patent filings
20+years of connected research
2018National Teacher of the Year
01
What we do
Build evidence across mechanisms, cells, disease models and translational settings.
02
What we have
Longitudinal research platforms in NRF1, mitochondria, telomeres, MSCs and natural bioactives.
03
What we seek
Hospitals, international laboratories, CROs, manufacturers and venture partners.
Find the research capabilities and partner roles relevant to your next study.
SELECTED PROJECTS
Research you can build on.
Explore active research and established platforms, followed by emerging proposals. Each project shows its current stage and opportunities for collaboration.
RESEARCH GALAXY
Explore the orbit of questions, methods and translation.
Hover or click a galaxy. Lock-on focus reveals its research signal.
楊堉麟PRINCIPAL INVESTIGATOR
2026Active
Translational & Clinical Research
NRF1, Mitophagy & Lung-cancer Response
An active disease-model program examining how NRF1-linked mitochondrial quality control may shape lung-cancer treatment response.
2025–2026Active
Regenerative Medicine
NRF1, Telomere Regulation & Stem-cell Function
Mechanism-led research connecting NRF1, telomere maintenance and mitochondrial homeostasis with functional stem-cell outcomes.
2017–2026Active
Translational & Clinical Research
Mitochondrial Biology in Cancer Models
A sustained research portfolio using mitochondrial regulation and cellular stress biology to investigate cancer progression and treatment response.
2027Proposal
Regenerative Medicine
NRF × MSC Rejuvenation Platform
A translational program exploring how natural regenerative signaling may support measurable MSC quality and cellular resilience.
2026Proposal
Technology Commercialization
HerboChip Functional-guided Screening & Knowledge Transfer
A two-decade functional-guided discovery workflow is being organized into a reproducible, teachable and industry-auditable platform.
2026Proposal
Neuroscience & Healthy Aging
Mitochondrial Activation for Post-stroke Neural Repair
A proposed basic–clinical collaboration centered on mitochondrial dysfunction, oxidative stress and loss of neural plasticity after ischemic injury.
PUBLICATIONS
Follow the research through its published record.
49 public PubMed records are organized by research signal. Filter a direction, search a concept, then open the original article record.
6 of 49 records · each entry links to PubMed
2026
Cancer, Mitochondria & Cell Plasticity
NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma.
Verbascoside Suppresses Epithelial-Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer.